270 related articles for article (PubMed ID: 26702135)
1. Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity.
Hartmann P; Seebauer CT; Mazagova M; Horvath A; Wang L; Llorente C; Varki NM; Brandl K; Ho SB; Schnabl B
Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(5):G310-22. PubMed ID: 26702135
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
3. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
[TBL] [Abstract][Full Text] [Related]
4. Mesenteric adipose tissue contributes to intestinal barrier integrity and protects against nonalcoholic fatty liver disease in mice.
Wu Z; Tan J; Chi Y; Zhang F; Xu J; Song Y; Cong X; Wu N; Liu Y
Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G659-G670. PubMed ID: 29902065
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice.
Hartmann P; Chen P; Wang HJ; Wang L; McCole DF; Brandl K; Stärkel P; Belzer C; Hellerbrand C; Tsukamoto H; Ho SB; Schnabl B
Hepatology; 2013 Jul; 58(1):108-19. PubMed ID: 23408358
[TBL] [Abstract][Full Text] [Related]
6. Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature.
Kim S; Choi S; Dutta M; Asubonteng JO; Polunas M; Goedken M; Gonzalez FJ; Cui JY; Gyamfi MA
Biochem Pharmacol; 2021 Nov; 193():114698. PubMed ID: 34303710
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
[TBL] [Abstract][Full Text] [Related]
8. Probiotic mixture VSL#3 reduces colonic inflammation and improves intestinal barrier function in Muc2 mucin-deficient mice.
Kumar M; Kissoon-Singh V; Coria AL; Moreau F; Chadee K
Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G34-G45. PubMed ID: 27856417
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis.
Chiu CC; Ching YH; Li YP; Liu JY; Huang YT; Huang YW; Yang SS; Huang WC; Chuang HL
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29113135
[TBL] [Abstract][Full Text] [Related]
10. The Transplantation of ω3 PUFA-Altered Gut Microbiota of fat-1 Mice to Wild-Type Littermates Prevents Obesity and Associated Metabolic Disorders.
Bidu C; Escoula Q; Bellenger S; Spor A; Galan M; Geissler A; Bouchot A; Dardevet D; Morio B; Cani PD; Lagrost L; Narce M; Bellenger J
Diabetes; 2018 Aug; 67(8):1512-1523. PubMed ID: 29793999
[TBL] [Abstract][Full Text] [Related]
11. White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice.
Sakane S; Hikita H; Shirai K; Myojin Y; Sasaki Y; Kudo S; Fukumoto K; Mizutani N; Tahata Y; Makino Y; Yamada R; Kodama T; Sakamori R; Tatsumi T; Takehara T
Cell Mol Gastroenterol Hepatol; 2021; 12(5):1683-1699. PubMed ID: 34303881
[TBL] [Abstract][Full Text] [Related]
12. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.
Wang W; Zhao J; Gui W; Sun D; Dai H; Xiao L; Chu H; Du F; Zhu Q; Schnabl B; Huang K; Yang L; Hou X
Br J Pharmacol; 2018 Feb; 175(3):469-484. PubMed ID: 29139555
[TBL] [Abstract][Full Text] [Related]
13. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of heat-treated Enterococcus faecalis FK-23 on high-fat diet-induced hepatic steatosis in mice.
Kondoh M; Shimada T; Fukada K; Morita M; Katada K; Higashimura Y; Mizushima K; Okamori M; Naito Y; Yoshikawa T
Br J Nutr; 2014 Sep; 112(6):868-75. PubMed ID: 25089585
[TBL] [Abstract][Full Text] [Related]
15. Oral Exposure to Polystyrene Microplastics of Mice on a Normal or High-Fat Diet and Intestinal and Metabolic Outcomes.
Okamura T; Hamaguchi M; Hasegawa Y; Hashimoto Y; Majima S; Senmaru T; Ushigome E; Nakanishi N; Asano M; Yamazaki M; Sasano R; Nakanishi Y; Seno H; Takano H; Fukui M
Environ Health Perspect; 2023 Feb; 131(2):27006. PubMed ID: 36821708
[TBL] [Abstract][Full Text] [Related]
16. Surgical removal of inflamed epididymal white adipose tissue attenuates the development of non-alcoholic steatohepatitis in obesity.
Mulder P; Morrison MC; Wielinga PY; van Duyvenvoorde W; Kooistra T; Kleemann R
Int J Obes (Lond); 2016 Apr; 40(4):675-84. PubMed ID: 26499443
[TBL] [Abstract][Full Text] [Related]
17. Gut-Specific Delivery of T-Helper 17 Cells Reduces Obesity and Insulin Resistance in Mice.
Hong CP; Park A; Yang BG; Yun CH; Kwak MJ; Lee GW; Kim JH; Jang MS; Lee EJ; Jeun EJ; You G; Kim KS; Choi Y; Park JH; Hwang D; Im SH; Kim JF; Kim YK; Seoh JY; Surh CD; Kim YM; Jang MH
Gastroenterology; 2017 Jun; 152(8):1998-2010. PubMed ID: 28246016
[TBL] [Abstract][Full Text] [Related]
18. Heat-Inactivated
Morrison MC; Gart E; Duyvenvoorde WV; Snabel J; Nielsen MJ; Leeming DJ; Menke A; Kleemann R
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216439
[TBL] [Abstract][Full Text] [Related]
19. Intestinal mucosal barrier dysfunction participates in the progress of nonalcoholic fatty liver disease.
Mao JW; Tang HY; Zhao T; Tan XY; Bi J; Wang BY; Wang YD
Int J Clin Exp Pathol; 2015; 8(4):3648-58. PubMed ID: 26097546
[TBL] [Abstract][Full Text] [Related]
20. Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier.
Li Y; Liu T; Yan C; Xie R; Guo Z; Wang S; Zhang Y; Li Z; Wang B; Cao H
Mol Pharm; 2018 Sep; 15(9):3860-3870. PubMed ID: 30036479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
